Skip to main navigation
  • University of California San Francisco
  • About UCSF
  • Search UCSF
  • UCSF Medical Center
Boxer Lab
  • Treatment Trials
    • Clinical Trial List
      201809-UCSF-Adam-Boxer-0831
    • Participate in a Trial >
      • About Clinical Trials
      • Things to Consider
      • Inclusion/Exclusion Criteria
      • Trial Results
    • Resources >
      • Partner Projects
      • Brain Donor Program
      • Community Groups
    • Our Methods >
      • Measuring Benefits
      • Measuring Safety
      • Choosing a Therapy to Test
    • FAQ
    Infusion
  • Observational Studies
    • Overview
    • How Studies Work
    • Participate in a Study
    • Research Study List
      201809-UCSF-Adam-Boxer-0837
    Research
  • Research
    • Publications
      201809-UCSF-Adam-Boxer-1523
    • Careers & Training
    • Lectures
    • Collaborate with Us
  • About Us
    • History
      test
    • Mission/Vision
    • Our Methods >
      • Measuring Benefits
      • Measuring Safety
      • Choosing a Therapy to Test
      • Observational Studies
    • Team
    • News
      201809-UCSF-Adam-Boxer-1725[1]
    • Support and Funding
    • Staff Spotlight >
      • Current Spotlight
      • Previous Spotlights
    Boxer Lab, Sandler staircase
  • Contact
Show Search Form
Show Mobile Menu
Donate
Close Search Form

Search

Search
Sandler Building

News & Press

October 12th, 2023

$151M Grant Will Drive New Era in Alzheimer’s Treatments

UCSF
January 9th, 2023

Lecanemab

UCSF Memory and Aging Center
January 6th, 2023

FDA Grants Accelerated Approval for Alzheimer’s Disease Treatment

U.S. Food and Drug Administration
October 13th, 2022

Defining Biomarker Curves, Progression Models for Familial FTD

ALZFORUM
March 7th, 2022

2022 Norman Geschwind Prize recipient Dr. Julio Rojas

UCSF Department of Neurology
January 11th, 2022

Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer’s Disease

Centers for Medicare & Medicaid Services
November 23rd, 2021

More Tau Antibodies Bid Adieu; Semorinemab Keeps Foot in Door

ALZFORUM
November 22nd, 2021

The hunt for a simple blood test to detect Alzheimer’s disease

The Mercury News
September 8th, 2021

Interview with Dr VandeVrede, cognitive neurologist at the University of California San Francisco

Fédération des Centres Mémoire
July 15th, 2021

An Introduction to Amyloid-Related Imaging Abnormalities (ARIA) and Its Management - CME

Alzheimer's Association
June 8th, 2021

UCSF is among testing sites for new Alzheimer's drug

KTVU FOX 2
June 7th, 2021

Resources for Aducanumab

UCSF Memory and Aging Center
  • Load More
Logo Footer
  • Our Methods
  • About Us
  • Find a Trial
  • Contact Us
  • Participate
  • Work With Us
Donate
  • Facebook Icon
  • Twitter Icon
  • LinkedIn Icon

Copyright 2023 | Terms of Use | Privacy Policy

  • Treatment Trials
    • Clinical Trial List
      201809-UCSF-Adam-Boxer-0831
    • Participate in a Trial >
      • About Clinical Trials
      • Things to Consider
      • Inclusion/Exclusion Criteria
      • Trial Results
    • Resources >
      • Partner Projects
      • Brain Donor Program
      • Community Groups
    • Our Methods >
      • Measuring Benefits
      • Measuring Safety
      • Choosing a Therapy to Test
    • FAQ
    Infusion
  • Observational Studies
    • Overview
    • How Studies Work
    • Participate in a Study
    • Research Study List
      201809-UCSF-Adam-Boxer-0837
    Research
  • Research
    • Publications
      201809-UCSF-Adam-Boxer-1523
    • Careers & Training
    • Lectures
    • Collaborate with Us
  • About Us
    • History
      test
    • Mission/Vision
    • Our Methods >
      • Measuring Benefits
      • Measuring Safety
      • Choosing a Therapy to Test
      • Observational Studies
    • Team
    • News
      201809-UCSF-Adam-Boxer-1725[1]
    • Support and Funding
    • Staff Spotlight >
      • Current Spotlight
      • Previous Spotlights
    Boxer Lab, Sandler staircase
  • Contact